Aarti Pharmalabs Ltd

  • BSE Code : 543748
  • NSE Symbol : AARTIPHARM
  • ISIN : INE0LRU01027
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 864.00 -47.20(-5.18%)

Open Price ()

911.20

Prev. Close ()

911.20

Volume (No’s)

305,093

Market Cap ()

7,830.83

Low Price ()

857.40

High Price ()

918.35

 

Book Closure

From Date To Date Announcement
12-Aug-2025 NA Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve The unaudited financial results (standalone and consolidated) for the quarter ended June 30 2025.
12-Aug-2025 NA Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve The unaudited financial results (standalone and consolidated) for the quarter ended June 30 2025.
10-May-2025 NA Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 inter alia to consider and approve the audited financial results (standalone and consolidated) for the quarter and year ended March 31 2025 and recommendation of dividend if any for the financial year ended March 31 2025. The Audited Financial Results and Statements of the Company (Standalone and Consolidated) for the Quarter and Year ended March 31, 2025, based on the recommendation of the Audit Committee. (As Per BSE Announcement Dated on :10.05.2025)
31-Mar-2025 NA The declaration of Interim Dividend of 2.5/- (@ 50%) per Equity Share of I5/- each for the Financial Year 2024-25. Further, please note that as per the Regulation 42(1)(a) of the SEBI (LODR) Regulations, 2015, Friday, February 14, 2025 has been fixed as Record Date' for the purpose of payment of Interim Dividend.
31-Mar-2025 NA Recommended dividend of Rs. 2.50 /- (50%) (Rupees Two and Paise Fifty only) per Equity Share of Face Value of Rs. 5/- each for the Financial Year ended March 31, 2025, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew